| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |